Rifaxigress 550mg 10 Tablets

babies: it is not applicable for babies. lactating mothers: it is safe to use this medication in breastfeeding mothers.
studies showed that drug does not pass through breast milk affects developing babies. consult your doctor before using this medicine.
pregnancy: it is unsafe to use this medication in pregnancy. studies showed that drug affects the developing fetus.
consult your doctor before using this medicine. driving: it is safe to drive while using this medication. alcohol: limited information is available.
consult your doctor before taking this medication with alcohol. liver: use this medication with caution in liver disease patients. you may require dose adjustments in some cases.
consult your doctor before using this medicine. kidney: rifaxigress tablets are safe to use in kidney disease patients. you may not require any dose adjustments.
consult your doctor before using this medicine..

headache dizziness nausea vomiting.

rifaxigress tablet is an antibiotic. it helps to relieve the symptoms of hepatic encephalopathy by killing the ammonia-producing bacteria in the gastrointestinal tract.
it helps to treat infection and also decreases the recurrence of further episodes of hepatic encephalopathy..

if you miss a dose, take it as soon as possible. if it is near the time of the next dose, then skip the missed dose.
take the prescribed dose on your regular time daily. don't double the dose to catch up with the missed dose..

• rifaxigress tablet is helpful to treat hepatic encephalopathy, infectious diarrhoea, and irritable bowel disease with diarrhoea. • take this medicine with or without food. • this medication should take only if your doctor prescribes you. • this medication should take every day at the same time to get better outcomes. • complete the treatment course. • don’t miss a dose. • this medication may cause reddish discolouration of urine..

major • rifaxigress + cholera vaccine: concurrent use of these drugs may decrease the immune response to the cholera vaccine moderate • rifaxigress + lixisenatide: concurrent use of these drugs may result in a delayed therapeutic effect • rifaxigress + warfarin: concurrent use of these drugs may decrease anticoagulant efficacy of warfarin.